Biogen reported $2.65B in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
ALKERMES ALKS:US 310.68M 5.55M
Amgen AMGN:US $ 4.42B 680M
Bayer BAYN:GR 12.65B 2.22B
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Gilead Sciences GILD:US $ 4231M 2162M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
Marinus Pharmaceuticals MRNS:US $ 38.56M 7.66M
Merk MRK:US $ 9666M 666M
Moderna Inc MRNA:US 2.3B 463M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
YTE INCY:US $ 656.97M 40.27M